Koninklijke Philips N.V. $PHG Shares Bought by Allworth Financial LP

Allworth Financial LP grew its holdings in shares of Koninklijke Philips N.V. (NYSE:PHG) by 73.1% in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 8,030 shares of the technology company’s stock after buying an additional 3,392 shares during the quarter. Allworth Financial LP’s holdings in Koninklijke Philips were worth $193,000 at the end of the most recent quarter.

A number of other institutional investors have also made changes to their positions in the company. Whipplewood Advisors LLC raised its position in shares of Koninklijke Philips by 39.1% in the 2nd quarter. Whipplewood Advisors LLC now owns 2,108 shares of the technology company’s stock valued at $51,000 after purchasing an additional 592 shares in the last quarter. Caitong International Asset Management Co. Ltd lifted its holdings in shares of Koninklijke Philips by 1,170.3% in the 1st quarter. Caitong International Asset Management Co. Ltd now owns 2,439 shares of the technology company’s stock worth $62,000 after purchasing an additional 2,247 shares during the last quarter. Blue Trust Inc. boosted its position in Koninklijke Philips by 30.0% during the 2nd quarter. Blue Trust Inc. now owns 4,408 shares of the technology company’s stock valued at $106,000 after purchasing an additional 1,017 shares during the period. Bessemer Group Inc. increased its holdings in shares of Koninklijke Philips by 125.2% in the 2nd quarter. Bessemer Group Inc. now owns 4,443 shares of the technology company’s stock worth $106,000 after acquiring an additional 2,470 shares during the period. Finally, Wealthquest Corp acquired a new position in shares of Koninklijke Philips during the first quarter worth approximately $116,000. 13.67% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

PHG has been the subject of several recent analyst reports. Weiss Ratings reiterated a “hold (c-)” rating on shares of Koninklijke Philips in a report on Thursday, November 13th. Wall Street Zen cut Koninklijke Philips from a “buy” rating to a “hold” rating in a report on Saturday, August 2nd. One research analyst has rated the stock with a Strong Buy rating, two have given a Buy rating and one has assigned a Hold rating to the company. According to data from MarketBeat, Koninklijke Philips currently has a consensus rating of “Buy”.

Koninklijke Philips Stock Performance

NYSE:PHG opened at $27.53 on Wednesday. The firm has a market capitalization of $26.51 billion, a PE ratio of 137.65, a PEG ratio of 0.74 and a beta of 0.82. Koninklijke Philips N.V. has a 1 year low of $21.48 and a 1 year high of $29.54. The company has a current ratio of 1.32, a quick ratio of 0.86 and a debt-to-equity ratio of 0.68. The firm’s fifty day simple moving average is $28.01 and its 200 day simple moving average is $26.06.

Koninklijke Philips (NYSE:PHG) last posted its quarterly earnings data on Tuesday, November 4th. The technology company reported $0.37 earnings per share for the quarter, meeting the consensus estimate of $0.37. Koninklijke Philips had a return on equity of 12.14% and a net margin of 1.07%.The company had revenue of $4.94 billion during the quarter, compared to analysts’ expectations of $4.30 billion. On average, sell-side analysts anticipate that Koninklijke Philips N.V. will post 1.63 EPS for the current year.

Koninklijke Philips Profile

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.